Study Chair Professor Sarah-Jane Dawson provides and update on the CAPTURE clinical trial.
CAPTURE is an Australian clinical trial which will enrol 140 patients. It is open to both women and men diagnosed with Oestrogen-receptor (ER) positive and Human Epidermal Growth Factor Receptor 2 (HER-2) negative breast cancer that has returned after treatment with a CDK4/6 inhibitor (such as ribociclib, palbociclib, abemaciclib). The CAPTURE clinical trial will investigate if treatment with a PI3K inhibitor (alpelisib), in combination with fulvestrant, will improve outcomes for patients with metastatic breast cancer when compared with standard treatment.
----------------------------------------------------------------
Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand committed to exploring and finding better treatments for people affected by breast cancer through clinical trials research.
Please like this video then visit www.breastcancertrials.org.au to find out more about our current breast cancer clinical trials that may be suitable for you, and ways in which you can help support breast cancer research.
----------------------------------------------------------------
SUBSCRIBE TO OUR YOUTUBE CHANNEL
[ Ссылка ]
LET'S CONNECT
Email ►enquiries@bctrials.org.au
Tel 1800 423 444
WWW ► [ Ссылка ]
Linkedin ► [ Ссылка ]
Twitter ► [ Ссылка ]
Facebook ► [ Ссылка ]
Instagram ► [ Ссылка ]
